Hasselwander Solveig, Xia Ning, Mimmler Maximilian, Ascher Stefanie, Knopp Tanja, Reifenberg Gisela, Karbach Susanne, Ruf Wolfram, Reinhardt Christoph, Li Huige
Department of Pharmacology, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany.
Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Langenbeckstr. 1, 55131 Mainz, Germany.
Heliyon. 2022 Nov 17;8(11):e11740. doi: 10.1016/j.heliyon.2022.e11740. eCollection 2022 Nov.
Cells of the innate immune system, including monocytes and neutrophils, are key players in the process of venous thrombosis. T lymphocytes have recently been implicated in venous thrombus resolution but the role of B lymphocytes in thrombosis is unknown. The present study was conducted to address this question using a mouse model of partial ligation of the inferior vena cava. Although only a very low number of B cells was found in the venous thrombi of wild-type mice, B cell-deficient JHT mutant mice developed larger venous thrombi than the wild-type controls. Consistent with enhanced thrombogenesis, increased neutrophil counts were found in the circulating blood and in the thrombi of B cell-deficient mice. One of the mechanisms by which neutrophils contribute to venous thrombosis is the formation of neutrophil extracellular traps (NETs). In agreement, higher quantities of NETs were observed in the thrombi of B cell-deficient mice. assays showed no difference in the NET building capacity of the isolated neutrophils between B cell-deficient and wild-type mice, indicating that the enhanced NET formation in the thrombi of B cell-deficient mice is attributable to the increased number of circulating neutrophils in these animals. Furthermore, increased concentration of the clot-stabilizing macromolecule fibrinogen was detected in the plasma of B cell-deficient mice. In conclusion, B cell-deficiency in mice indirectly promotes venous thrombosis by increasing neutrophil numbers and elevating fibrinogen levels.
包括单核细胞和中性粒细胞在内的先天免疫系统细胞是静脉血栓形成过程中的关键参与者。T淋巴细胞最近被认为与静脉血栓溶解有关,但B淋巴细胞在血栓形成中的作用尚不清楚。本研究使用下腔静脉部分结扎的小鼠模型来解决这个问题。尽管在野生型小鼠的静脉血栓中仅发现极少量的B细胞,但B细胞缺陷的JHT突变小鼠形成的静脉血栓比野生型对照更大。与血栓形成增强一致,在B细胞缺陷小鼠的循环血液和血栓中发现中性粒细胞计数增加。中性粒细胞促进静脉血栓形成的机制之一是形成中性粒细胞胞外陷阱(NETs)。与此一致,在B细胞缺陷小鼠的血栓中观察到更高数量的NETs。检测显示,B细胞缺陷小鼠和野生型小鼠分离出的中性粒细胞在NET形成能力上没有差异,这表明B细胞缺陷小鼠血栓中NET形成增加归因于这些动物循环中性粒细胞数量的增加。此外,在B细胞缺陷小鼠的血浆中检测到凝血稳定大分子纤维蛋白原的浓度增加。总之,小鼠中的B细胞缺陷通过增加中性粒细胞数量和提高纤维蛋白原水平间接促进静脉血栓形成。